153 related articles for article (PubMed ID: 36136256)
1. A cytotoxic effect of human lactoferrin fusion with Fc domain of IgG.
Zaczyńska E; Kocięba M; Artym J; Kochanowska I; Kruzel ML; Zimecki M
Biometals; 2023 Jun; 36(3):617-627. PubMed ID: 36136256
[TBL] [Abstract][Full Text] [Related]
2. Optimized lactoferrin as a highly promising treatment for intracerebral hemorrhage: Pre-clinical experience.
Zhao X; Kruzel M; Ting SM; Sun G; Savitz SI; Aronowski J
J Cereb Blood Flow Metab; 2021 Jan; 41(1):53-66. PubMed ID: 32438861
[TBL] [Abstract][Full Text] [Related]
3. Modulation of TDM-induced granuloma pathology by human lactoferrin: a persistent effect in mice.
Actor JK; Nguyen TKT; Wasik-Smietana A; Kruzel ML
Biometals; 2023 Jun; 36(3):603-615. PubMed ID: 35976499
[TBL] [Abstract][Full Text] [Related]
4. Extraordinarily potent proinflammatory properties of lactoferrin-containing immunocomplexes against human monocytes and macrophages.
Hu L; Hu X; Long K; Gao C; Dong HL; Zhong Q; Gao XM; Gong FY
Sci Rep; 2017 Jun; 7(1):4230. PubMed ID: 28652573
[TBL] [Abstract][Full Text] [Related]
5. M860, a Monoclonal Antibody against Human Lactoferrin, Enhances Tumoricidal Activity of Low Dosage Lactoferrin via Granzyme B Induction.
Li Y; Li J; Gong Z; Pan XH; Ma ZH; Ma SY; Wang HM; Dong HL; Gong FY; Gao XM
Molecules; 2019 Oct; 24(20):. PubMed ID: 31600968
[TBL] [Abstract][Full Text] [Related]
6. Monocyte and NK cell cytotoxic activity in human adherent cell preparations: discriminating effects of interferon and lactoferrin.
Horwitz DA; Bakke AC; Abo W; Nishiya K
J Immunol; 1984 May; 132(5):2370-4. PubMed ID: 6201542
[TBL] [Abstract][Full Text] [Related]
7. Contrasting effects of lactoferrin on human lymphocyte and monocyte natural killer activity and antibody-dependent cell-mediated cytotoxicity.
Nishiya K; Horwitz DA
J Immunol; 1982 Dec; 129(6):2519-23. PubMed ID: 7142699
[TBL] [Abstract][Full Text] [Related]
8. Selective role of mevalonate pathway in regulating perforin but not FasL and TNFalpha release in human Natural Killer cells.
Poggi A; Boero S; Musso A; Zocchi MR
PLoS One; 2013; 8(5):e62932. PubMed ID: 23667543
[TBL] [Abstract][Full Text] [Related]
9. A Novel Murine Anti-Lactoferrin Monoclonal Antibody Activates Human Polymorphonuclear Leukocytes through Membrane-Bound Lactoferrin and TLR4.
Hu XM; Xu YR; Yan R; Sun SL; Dong HL; Wang J; Gao XM
Biomed Res Int; 2015; 2015():285237. PubMed ID: 26649297
[TBL] [Abstract][Full Text] [Related]
10. Granzyme B expression is enhanced in human monocytes by TLR8 agonists and contributes to antibody-dependent cellular cytotoxicity.
Elavazhagan S; Fatehchand K; Santhanam V; Fang H; Ren L; Gautam S; Reader B; Mo X; Cheney C; Briercheck E; Vasilakos JP; Dietsch GN; Hershberg RM; Caligiuri M; Byrd JC; Butchar JP; Tridandapani S
J Immunol; 2015 Mar; 194(6):2786-95. PubMed ID: 25667415
[TBL] [Abstract][Full Text] [Related]
11. Granzyme B Cleaves Multiple Herpes Simplex Virus 1 and Varicella-Zoster Virus (VZV) Gene Products, and VZV ORF4 Inhibits Natural Killer Cell Cytotoxicity.
Gerada C; Steain M; Campbell TM; McSharry B; Slobedman B; Abendroth A
J Virol; 2019 Nov; 93(22):. PubMed ID: 31462576
[TBL] [Abstract][Full Text] [Related]
12. Lactoferrin-Containing Immunocomplexes Drive the Conversion of Human Macrophages from M2- into M1-like Phenotype.
Gao CH; Dong HL; Tai L; Gao XM
Front Immunol; 2018; 9():37. PubMed ID: 29410669
[TBL] [Abstract][Full Text] [Related]
13. The IL-15-Based ALT-803 Complex Enhances FcγRIIIa-Triggered NK Cell Responses and In Vivo Clearance of B Cell Lymphomas.
Rosario M; Liu B; Kong L; Collins LI; Schneider SE; Chen X; Han K; Jeng EK; Rhode PR; Leong JW; Schappe T; Jewell BA; Keppel CR; Shah K; Hess B; Romee R; Piwnica-Worms DR; Cashen AF; Bartlett NL; Wong HC; Fehniger TA
Clin Cancer Res; 2016 Feb; 22(3):596-608. PubMed ID: 26423796
[TBL] [Abstract][Full Text] [Related]
14. Effects of human lactoferrin on NK cell cytotoxicity against haematopoietic and epithelial tumour cells.
Damiens E; Mazurier J; el Yazidi I; Masson M; Duthille I; Spik G; Boilly-Marer Y
Biochim Biophys Acta; 1998 Apr; 1402(3):277-87. PubMed ID: 9606986
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of natural killer cell cytotoxicity by interleukin-6: implications for the pathogenesis of macrophage activation syndrome.
Cifaldi L; Prencipe G; Caiello I; Bracaglia C; Locatelli F; De Benedetti F; Strippoli R
Arthritis Rheumatol; 2015 Nov; 67(11):3037-46. PubMed ID: 26251193
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of eosinophil migration by lactoferrin.
Bournazou I; Mackenzie KJ; Duffin R; Rossi AG; Gregory CD
Immunol Cell Biol; 2010 Feb; 88(2):220-3. PubMed ID: 19918259
[TBL] [Abstract][Full Text] [Related]
17. Hinge-Deficient IgG1 Fc Fusion: Application to Human Lactoferrin.
Shiga Y; Murata D; Sugimoto A; Oshima Y; Tada M; Ishii-Watabe A; Imai K; Tomii K; Takeuchi T; Kagaya S; Sato A
Mol Pharm; 2017 Sep; 14(9):3025-3035. PubMed ID: 28763236
[TBL] [Abstract][Full Text] [Related]
18. Beneficial Role of Neutrophils Through Function of Lactoferrin After Intracerebral Hemorrhage.
Zhao X; Ting SM; Sun G; Roy-O'Reilly M; Mobley AS; Bautista Garrido J; Zheng X; Obertas L; Jung JE; Kruzel M; Aronowski J
Stroke; 2018 May; 49(5):1241-1247. PubMed ID: 29636422
[TBL] [Abstract][Full Text] [Related]
19. Natural cytotoxicity of human blood monocytes and natural killer cells and their cytotoxic factors: discriminating effects of actinomycin D.
Uchida A; Klein E
Int J Cancer; 1985 May; 35(5):691-9. PubMed ID: 3997288
[TBL] [Abstract][Full Text] [Related]
20. Lactoferrin-containing immunocomplex mediates antitumor effects by resetting tumor-associated macrophages to M1 phenotype.
Dong H; Yang Y; Gao C; Sun H; Wang H; Hong C; Wang J; Gong F; Gao X
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32217759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
